Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Imaging in Patients With Prostate Cancer”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Early research (Phase 1)Study completedNCT01205321
What this trial is testing

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 19
Testing effectiveness (Phase 2)Study completedNCT04733768
What this trial is testing

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Alberta 100
Testing effectiveness (Phase 2)Looking for participantsNCT06259123
What this trial is testing

Neoadjuvant PSMA-RLT in Oligometastatic PCa

Who this might be right for
Prostate Cancer
Medical University of Vienna 10
Testing effectiveness (Phase 2)Looking for participantsNCT06617481
What this trial is testing

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

Who this might be right for
Prostate Cancer (Post Prostatectomy)
AdventHealth 30
Not applicableApproved For MarketingNCT04452136
What this trial is testing

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic DiseasesProstate Cancer+2 more
Jeanne Link
Not applicableStudy completedNCT00392938
What this trial is testing

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic CancerProstate Cancer
University of Washington 11
Testing effectiveness (Phase 2)Study completedNCT06472531
What this trial is testing

PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer

Who this might be right for
Healthy Male SubjectsSuspected Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 32
Testing effectiveness (Phase 2)Looking for participantsNCT07689656
What this trial is testing

A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Testing effectiveness (Phase 2)Study completedNCT05653856
What this trial is testing

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate (Disorder)
Curium US LLC 26
Not applicableStudy completedNCT00605488
What this trial is testing

The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer

Who this might be right for
Breast CancerHead and Neck CancerProstate Cancer
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07025369
What this trial is testing

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more
Mayo Clinic 30
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableNot Yet RecruitingNCT07747493
What this trial is testing

68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy

Who this might be right for
Prostate Cancer (Adenocarcinoma)Localized Prostate Cancer
University Health Network, Toronto 8
Not applicableStudy completedNCT03486886
What this trial is testing

PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility

Who this might be right for
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 29
Not applicableStudy completedNCT03187990
What this trial is testing

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Who this might be right for
Prostate Cancer
Irene Burger 52
Large-scale testing (Phase 3)Active Not RecruitingNCT05936658
What this trial is testing

[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer

Who this might be right for
High Risk Prostate Carcinoma
FutureChem 138
Large-scale testing (Phase 3)Study completedNCT03353740
What this trial is testing

Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence

Who this might be right for
Prostate Cancer
Thomas Hope 346
Not applicableUnknownNCT02181192
What this trial is testing

Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma

Who this might be right for
Prostate CancerRecurrence
University of Erlangen-Nürnberg Medical School 180
Early research (Phase 1)Ended earlyNCT04528199
What this trial is testing

[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04777071
What this trial is testing

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma+3 more
University of Washington 141
Next Page